12 reports

  • GENOMIC VISION ENTERS INTO DISTRIBUTION AGREEMENT WITH AMCARE GENOMICS LABORATORY
  • Genomic Vision SA, Key Competitors

Summary Genomic Vision (Genomic) is a molecular diagnostics and technology company that develops and commercializes diagnostic tests for genetic diseases and cancers.The company’s portfolio comprises tests for breast cancer and colon cancer, diagnostic solution for facio-scapulo-humeral muscular dystrophy; and tools for...

  • Cytogenetic
  • Genomics
  • France
  • Demand
  • Genomic Vision SA
  • GENOMIC VISION ENTERS INTO DISTRIBUTION AGREEMENT WITH AMCARE GENOMICS LABORATORY
  • Genomic Vision SA, Key Competitors

Summary Genomic Vision (Genomic) is a molecular diagnostics and technology company that develops and commercializes diagnostic tests for genetic diseases and cancers.The company’s portfolio comprises tests for breast cancer and colon cancer, diagnostic solution for facio-scapulo-humeral muscular dystrophy; and tools for...

  • Cytogenetic
  • Genomics
  • France
  • Demand
  • Genomic Vision SA
  • GENOMIC VISION, KEY EMPLOYEES
  • GENOMIC VISION, KEY COMPETITORS

Summary Genomic Vision (Genomic) is a molecular diagnostics and technology company that develops and commercializes diagnostic tests for genetic diseases and cancers.The company’s portfolio comprises tests for breast cancer and colon cancer, diagnostic solution for facio-scapulo-humeral muscular dystrophy; and tools for...

  • Genomics
  • Healthcare
  • Pharmaceutical
  • France
  • Demand
  • Quantum Genomics SA - Locations And Subsidiaries
  • Quantum Genomics SA, Key Competitors

Summary Quantum Genomics SA (Quantum Genomics) is a biopharmaceutical company which develops novel medicines in the field of cardiovascular diseases.The company develops drugs to treat high blood pressure and heart failure. Its research programs are based on the Brain Aminopeptidase A Inhibition (BAPAI), a real triple...

  • Genomics
  • Healthcare
  • Hypertension
  • Pharmaceutical
  • France
  • PARTNERSHIPS
  • INTEGRAGEN ENTERS INTO DISTRIBUTION AGREEMENT WITH TWIST BIOSCIENCE

A distribution agreement for these software tools with Twist Bioscience, one of the leaders in the field of targeted DNA capture kits, was announced in February 2018.

  • Genomics
  • France
  • Company
  • Company Financials
  • IntegraGen
  • DIAGNOSTIC TEST - HEPATOCELLULAR CARCINOMA - PRODUCT DESCRIPTION
  • INTEGRAGEN SA PIPELINE PRODUCTS AND ONGOING CLINICAL TRIALS OVERVIEW

Summary IntegraGen SA (IntegraGen) is a developer and commercializer of molecular diagnostic tests for the treatment of autism and oncology.The company provides advanced genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis, agrigenomics, and genomics...

  • Genomics
  • Lung Cancer
  • France
  • Company Financials
  • IntegraGen
  • Deal Rationale
  • Deal Type

Summary IntegraGen SA (IntegraGen) is a developer and commercializer of molecular diagnostic tests for the treatment of autism and oncology.The company provides advanced genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis, agrigenomics, and genomics...

  • Genomics
  • France
  • Company
  • Company Financials
  • IntegraGen

In Uruguay, Genia is one of the major regional actors in clinical genomics.

  • Artificial Intelligence
  • Genomics
  • Hospital
  • Molecular Diagnostic
  • France
  • INTEGRAGEN RAISES USD4 MILLION IN PRIVATE PLACEMENT OF SHARES
  • 7.4 PRODUCT NEWS

France Genetic Testing Market Outlook to 2024 Summary GlobalData’s new report, France Genetic Testing Market Outlook to 2024, provides key market data on the France Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations,...

  • Genetic
  • Genomics
  • France
  • United States
  • Demand
  • INTEGRAGEN RAISES USD4 MILLION IN PRIVATE PLACEMENT OF SHARES
  • LABORATOIRE CERBA ENTERS INTO LICENSING AGREEMENT WITH INTEGRAGEN

France In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture Summary GlobalData’s new report, France In Vitro Diagnostics (IVD) Market Outlook to 2024, provides...

  • Genomics
  • Medical Device
  • France
  • Forecast
  • bioMerieux S.A.
  • FIRALIS SAS PIPELINE PRODUCTS AND ONGOING CLINICAL TRIALS OVERVIEW

It offers biomarker services such as flow cytometry, metabolomics and lipidomics, proteomics, genomics and transcriptomics, biobanking services, biomarker data analysis services, assay development and biomarker regulatory consultancy services, among others.

  • Chronic Disease
  • Genomics
  • France
  • Supply
  • Firalis SAS
  • KROMATID ENTERS INTO DISTRIBUTION AGREEMENT WITH TEBU-BIO
  • TATAA BIOCENTER ENTERS INTO LICENSING AGREEMENT WITH INSERM FOR VALIDPRIME TECHNOLOGY

Other genetic tests include pharmaco-genomics which include test related to cytochrome P## (CYP ##).

  • Genomics
  • In Vitro Diagnostics
  • Medical Device
  • France
  • bioMerieux S.A.